Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma ( Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA )
11 Dec 2021

ZUMA-12: A phase 2 study of axi-cel as first-line therapy in patients with high-risk large B-cell lymphoma (LBCL)

Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA
ZUMA-12: A phase 2 study of axi-cel as first-line therapy in patients with high-risk large B-cell lymphoma (LBCL) ( Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Dec 2021

Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma

Prof Elizabeth Budde - City of Hope, Duarte, USA
Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma ( Prof Elizabeth Budde - City of Hope, Duarte, USA )
11 Dec 2021

Initial treatment options for relapsed/refractory multiple myeloma patients

Dr Maria-Victoria Mateos - University Hospital of Salamanca-IBSAL, Salamanca, Spain
Initial treatment options for relapsed/refractory multiple myeloma patients ( Dr Maria-Victoria Mateos - University Hospital of Salamanca-IBSAL, Salamanca, Spain )
11 Dec 2021

Latest in advanced endometrial cancer

Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote
Latest in advanced endometrial cancer ( Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote )
9 Dec 2021

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Dec 2021

Paediatric ALL perspective

Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
Paediatric ALL perspective ( Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy )
12 Nov 2021

OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
26 Oct 2021

WCLC 2021: Epidemiology of MET Exon 14 mutations

Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht Stenzinger
WCLC 2021: Epidemiology of MET Exon 14 mutations ( Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht Stenzinger )
19 Oct 2021

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
18 Oct 2021

ESMO 2021: Latest in EGFR mutated advanced NSCLC

Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera
ESMO 2021: Latest in EGFR mutated advanced NSCLC ( Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera )
11 Oct 2021

First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA

Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA
First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA ( Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA )
6 Oct 2021